Quantifying Transmission of Clostridium difficile within and outside Healthcare Settings

Empirical quantification of transmission dynamics for all settings is needed when evaluating interventions and control strategies.

• Publication year

  2016

• Venue

  Emerging Infectious Diseases

• Publication date

  2016-04-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.3201/eid2204.150455PMID 26982504PMCID 4806959
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HEALTHCARE COST AND UTILIZATION PROJECT

  2017cited by this paper
• Asymptomatic Carriers of Toxigenic C. difficile in Long-Term Care Facilities: A Meta-Analysis of Prevalence and Risk Factors

  2015cited by this paper
• Prevalence and risk factors for asymptomatic Clostridium difficile carriage.

  2014cited by this paper
• Prevalence and Duration of Asymptomatic Clostridium difficile Carriage among Healthy Subjects in Pittsburgh, Pennsylvania

  2014influential reference
• A Mathematical Model to Evaluate the Routine Use of Fecal Microbiota Transplantation to Prevent Incident and Recurrent Clostridium difficile Infection

  2014cited by this paper
• Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial.

  2013cited by this paper
• Long-Term Care Services in the United States: 2013 Overview.

  2013cited by this paper
• Diverse sources of C. difficile infection identified on whole-genome sequencing.

  2013cited by this paper
• All-cause and disease-specific mortality in hospitalized patients with Clostridium difficile infection: a multicenter cohort study.

  2013cited by this paper
• A Simulation-Based Assessment of Strategies to Control Clostridium Difficile Transmission and Infection

  2013cited by this paper
• Clostridium difficile exposure as an insidious source of infection in healthcare settings: an epidemiological model

  2013cited by this paper
• U.S. outpatient antibiotic prescribing, 2010.

  2013cited by this paper
• Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients.

  2013cited by this paper
• Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control.

  2013cited by this paper
• Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.

  2013cited by this paper
• Community-associated Clostridium difficile infection and antibiotics: a meta-analysis.

  2013cited by this paper
• Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.

  2013cited by this paper
• Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009.

  2013cited by this paper
• Characterisation of Clostridium difficile Hospital Ward–Based Transmission Using Extensive Epidemiological Data and Molecular Typing

  2012cited by this paper
• Burden of Clostridium difficile Infection in Long-Term Care Facilities in Monroe County, New York

  2012cited by this paper
• Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics.

  2012cited by this paper
• Geographic variation in outpatient antibiotic prescribing among older adults.

  2012cited by this paper
• Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin

  2012cited by this paper
• Incidence of and risk factors for community-associated Clostridium difficile infection: A nested case-control study

  2011cited by this paper
• Epidemiological Model for Clostridium difficile Transmission in Healthcare Settings

  2011cited by this paper
• Benchmarking risk-adjusted adult antibacterial drug use in 70 US academic medical center hospitals.

  2011cited by this paper
• Infection prevention and control practices related to Clostridium difficile infection in Canadian acute and long-term care institutions.

  2011cited by this paper
• Host and pathogen factors for Clostridium difficile infection and colonization.

  2011cited by this paper
• Treatment with monoclonal antibodies against Clostridium difficile toxins.

  2010cited by this paper
• Multicenter Study of Clostridium difficile Infection Rates from 2000 to 2006

  2010cited by this paper
• Targeting residents for transitions from nursing home to community.

  2010cited by this paper
• Management of Clostridium difficile infection: thinking inside and outside the box.

  2010cited by this paper
• Disease transmission model for community-associated Clostridium difficile infection

  2010cited by this paper
• Spatio-temporal stochastic modelling of Clostridium difficile.

  2009cited by this paper
• National point prevalence of Clostridium difficile in US health care facility inpatients, 2008.

  2009cited by this paper
• The National Nursing Home Survey: 2004 overview.

  2009cited by this paper
• Increase in Adult Clostridium difficile–related Hospitalizations and Case-Fatality Rate, United States, 2000–2005

  2008cited by this paper
• Attributable Outcomes of Endemic Clostridium difficile–associated Disease in Nonsurgical Patients

  2008cited by this paper
• Comparison of Real-Time PCR for Detection of the tcdC Gene with Four Toxin Immunoassays and Culture in Diagnosis of Clostridium difficile Infection

  2008cited by this paper
• Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection

  2008cited by this paper
• The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences.

  2007cited by this paper
• Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease.

  2007cited by this paper
• Clostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–2003

  2006cited by this paper
• Global burden of hypertension: analysis of worldwide data.

  2005cited by this paper
• Molecular Epidemiology of Hospital-Associated and Community-Acquired Clostridium difficile Infection in a Swedish County

  2004cited by this paper
• Overview

  2004cited by this paper
• Epidemiology and Molecular Characterization of Clostridium difficile Strains from Patients with Diarrhea: Low Disease Incidence and Evidence of Limited Cross-Infection in a Swedish Teaching Hospital

  2003cited by this paper
• Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

  2002cited by this paper
• Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile.

  2002cited by this paper
• Efficient Exact Stochastic Simulation of Chemical Systems with Many Species and Many Channels

  2000influential reference
• Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

  2000cited by this paper
• Antimicrobial prescribing in long-term care facilities: prospective evaluation of potential antimicrobial use and cost indicators.

  1999cited by this paper
• Comorbidity measures for use with administrative data.

  1998cited by this paper
• Hospital-acquired Clostridium difficile diarrhoea and herd immunity.

  1997cited by this paper
• A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease.

  1994cited by this paper
• Infection due to Clostridium difficile among elderly residents of a long-term-care facility.

  1993cited by this paper
• National Hospital Discharge Survey.

  1989cited by this paper

• From Data to Decisions: Leveraging Large, Real-World Databases to Guide Clinical Practice in C. difficile Infections

  2025cites this paper
• Investigating in-hospital transmission of Clostridioides difficile from asymptomatic patients.

  2025cites this paper
• Quantitative summarization of high-touch surfaces and epidemiological parameters of Clostridioides difficile acquisition and transmission for mathematical modeling: a systematic review

  2025cites this paper
• Identifying Contact Time Required for Secondary Transmission of Clostridioides difficile Infections by Using Real-Time Locating System

  2024cites this paper
• Development of a Prediction Model to Identify the Risk of Clostridioides difficile Infection in Hospitalized Patients Receiving at Least One Dose of Antibiotics

  2024cites this paper
• Diagnostic stewardship to improve patient outcomes and healthcare-associated infection (HAI) metrics

  2024cites this paper
• Genomic surveillance of Clostridioides difficile transmission and virulence in a healthcare setting

  2024cites this paper
• The contribution of community transmission to the burden of hospital-associated pathogens: A systematic scoping review of epidemiological models

  2024influential citation
• Importance of underlying mechanisms for interpreting relative risk of Clostridioides difficile infection among antibiotic-exposed patients in healthcare facilities

  2024cites this paper
• A novel approach to correcting attribution of Clostridioides difficile in a healthcare setting

  2023cites this paper
• Genomic epidemiology and transmission dynamics of recurrent Clostridioides difficile infection in Western Australia

  2023cites this paper
• Agent-Based Model Framework for the North Carolina Modeling Infectious Diseases Program (NC MInD ABM) Overview, Design Concepts, and Details Protocol

  2022cites this paper
• One-day prevalence of asymptomatic carriage of toxigenic and non-toxigenic Clostridioides difficile in 10 French hospitals.

  2022cites this paper
• A review of epidemiological models of Clostridioides difficile transmission and control (2009-2021).

  2022cites this paper
• Agricultural fertilization with poultry manure results in persistent environmental contamination with the pathogen Clostridioides difficile

  2021cites this paper
• Clostridium Difficile and COVID-19: General Data, Ribotype, Clinical Form, Treatment-Our Experience from the Largest Infectious Diseases Hospital in Western Romania

  2021cites this paper
• Microbiome-pathogen interactions drive epidemiological dynamics of antibiotic resistance: A modeling study applied to nosocomial pathogen control

  2021cites this paper
• North Carolina COVID-19 Agent-Based Model Framework for Hospitalization Forecasting Overview, Design Concepts, and Details Protocol

  2021cites this paper
• Epidemiology of community-acquired and recurrent Clostridioides difficile infection

  2021cites this paper
• Transmission Dynamics of Clostridioides difficile in 2 High-Acuity Hospital Units.

  2021cites this paper
• Fecal Microbiota Transplants Annually and Their Positive Clinical Impact

  2020cites this paper
• Differences in time-to-testing and time-to-isolation between community-onset and hospital-onset Clostridioides difficile cases at a tertiary care VA medical center.

  2020cites this paper
• Strategies to prevent adverse outcomes following Clostridioides difficile infection in the elderly

  2020cites this paper
• Effectiveness and cost-effectiveness of a Clostridium difficile vaccine candidate in a hospital setting.

  2020cites this paper
• Modeling inpatient and outpatient antibiotic stewardship interventions to reduce the burden of Clostridioides difficile infection in a regional healthcare network

  2020influential citation
• Interventions to improve appropriate antibiotic prescribing in long-term care facilities: a systematic review

  2020cites this paper
• Modeling the potential impact of administering vaccines against Clostridioides difficile infection to individuals in healthcare facilities.

  2020cites this paper
• Impact of the coronavirus disease 2019 (COVID-19) pandemic on nosocomial Clostridioides difficile infection

  2020cites this paper
• The Clinical Burden of Clostridioides difficile in Ontario, Canada

  2019cites this paper
• Primary care clinics can be a source of exposure to virulent Clostridium (now Clostridioides) difficile: An environmental screening study of hospitals and clinics in Dallas-Fort Worth region

  2019cites this paper
• ON CALIBRATING A MICROSIMULATION OF PATIENT MOVEMENT THROUGH A HEALTHCARE NETWORK

  2019cites this paper
• Epidemiology of Clostridioides difficile Infection in Long-Term Care Facilities

  2019cites this paper
• Modelling microbial infection to address global health challenges

  2019cites this paper
• Creation of a Geospatially Explicit, Agent-based Model of a Regional Healthcare Network with Application to Clostridioides difficile Infection

  2019cites this paper
• Spatial clustering and livestock exposure as risk factor for community-acquired Clostridium difficile infection.

  2019cites this paper
• Seasonality of Clostridium difficile in the natural environment.

  2019cites this paper
• Incidence of Clostridioides difficile infections among young and middle-aged adults: Veterans Health Administration

  2019cites this paper
• Whole-genome sequencing reveals nosocomial Clostridioides difficile transmission and a previously unsuspected epidemic scenario

  2019cites this paper
• Seasonality and community interventions in a mathematical model of Clostridium difficile transmission.

  2019cites this paper
• New insights into transmission of Clostridium difficile infection-narrative review.

  2018cites this paper
• Two Distinct Patterns of Clostridium difficile Diversity Across Europe Indicating Contrasting Routes of Spread

  2018cites this paper
• Patient and Strain Characteristics Associated With Clostridium difficile Transmission and Adverse Outcomes

  2018cites this paper
• The Importance of C. difficile Colonization in Infection Prevention

  2018cites this paper
• Antibiotic resistant Gram-negative bacteria in long-term care facilities : an epidemiological and dynamic modelling study

  2018cites this paper
• Current management of Clostridioides (Clostridium) difficile infection in adults: a summary of recommendations from the 2017 IDSA/SHEA clinical practice guideline.

  2018cites this paper
• Reducing risk of Clostridium difficile infection and overall use of antibiotic in the outpatient treatment of urinary tract infection

  2018cites this paper
• Modelling diverse sources of Clostridium difficile in the community: importance of animals, infants and asymptomatic carriers

  2018cites this paper
• Clostridium difficile control measures: current and future methods for prevention

  2018cites this paper
• Assessing the effect of patient screening and isolation on curtailing Clostridium difficile infection in hospital settings

  2017cites this paper
• Healthcare-Associated Clostridium difficile Infections are Sustained by Disease from the Community

  2017cites this paper
• Risk Factors for Community‐Associated Clostridium difficile Infection in Children

  2017cites this paper
• Evolving Insights Into the Epidemiology and Control of Clostridium difficile in Hospitals

  2017cites this paper
• Genome Analysis of Clostridium difficile PCR Ribotype 014 Lineage in Australian Pigs and Humans Reveals a Diverse Genetic Repertoire and Signatures of Long-Range Interspecies Transmission

  2017cites this paper
• Contribution to Clostridium Difficile Transmission of Symptomatic Patients With Toxigenic Strains Who Are Fecal Toxin Negative

  2017cites this paper
• Personal Protective Equipment Use for Patients with Clostridium difficile

  2016cites this paper
• The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy.

  2016cites this paper